Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology ...
Two Joint Research Projects by Genecast and Professor Caicun Zhou’s Shanghai Pulmonary Hospital Team Selected for 2018 ESMO Poster Discussion
The European Society for Medical Oncology’s (ESMO) 2018 annual meeting will be held in Munich, ...
Agendia and Genecast Biotechnology Partner to Launch MammaPrint® and BluePrint® in China
For the first time, early-stage breast cancer patients and their physicians in China can access cl...
Genecast Biotechnology Announce Partnership To Advance Cancer Diagnosis in China
Genecast Biotechnology Co. Ltd. (Genecast) announced it has just reached strategic partnership agr...
Genecast Biotechnology Passed EMQN EQA
Recently, both Genecast’s Headquarter in Beijing and the Medical Laboratory in Wu’xi successfully ...